[PDF][PDF] Fluorine-18-fluorodeoxyglucose positron emission tomography for interim response assessment of advanced-stage Hodgkin's lymphoma and diffuse large B …
T Terasawa, J Lau, S Bardet, O Couturier, T Hotta… - J Clin …, 2009 - scholar.archive.org
Purpose To systematically review the prognostic accuracy of fluorine-18-fluorodeoxyglucose
positron emission tomography (FDG-PET) for interim response assessment of patients with …
positron emission tomography (FDG-PET) for interim response assessment of patients with …
Exploration and management of adrenal incidentalomas.: French Society of Endocrinology Consensus
A Tabarin, S Bardet, J Bertherat, B Dupas… - Annales d' …, 2008 - Elsevier
… with acquisitions at 60–90 s, and then 10 to 15 … S] × 100 where P is the attenuation value
at 60–90 s (hypothetical attenuation peak), R the value of attenuation at 10 or 15 minutes and S …
at 60–90 s (hypothetical attenuation peak), R the value of attenuation at 10 or 15 minutes and S …
[HTML][HTML] Strategies of radioiodine ablation in patients with low-risk thyroid cancer
…, S Zerdoud, B Bridji, S Bardet… - … England Journal of …, 2012 - Mass Medical Soc
Background It is not clear whether the administration of radioiodine provides any benefit to
patients with low-risk thyroid cancer after a complete surgical resection. The administration of …
patients with low-risk thyroid cancer after a complete surgical resection. The administration of …
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer
…, J Wadsley, D Führer, B Keam, S Bardet… - … England Journal of …, 2023 - Mass Medical Soc
Background Selpercatinib, a highly selective, potent RET inhibitor, has shown efficacy in
advanced RET-mutant medullary thyroid cancer in a phase 1–2 trial, but its efficacy as …
advanced RET-mutant medullary thyroid cancer in a phase 1–2 trial, but its efficacy as …
[HTML][HTML] Thyroidectomy without radioiodine in patients with low-risk thyroid cancer
…, AL Giraudet, N Le Moullec, S Bardet… - … England Journal of …, 2022 - Mass Medical Soc
Background In patients with low-risk differentiated thyroid cancer undergoing thyroidectomy,
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …
the postoperative administration of radioiodine (iodine-131) is controversial in the absence …
[HTML][HTML] Tree growth stress and related problems
J Gril, D Jullien, S Bardet, H Yamamoto - Journal of Wood Science, 2017 - Springer
… where E L and E T are Young’s moduli and ν LT and ν TL Poisson’s ratios, measured on
the samples. We must put a minus sign in front of each equation, because strains α L and α T …
the samples. We must put a minus sign in front of each equation, because strains α L and α T …
Omitting radiotherapy in early positron emission tomography–negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: clinical …
…, M Bellei, T van der Borght, S Bardet… - Journal of clinical …, 2014 - ascopubs.org
Purpose Combined-modality treatment is standard treatment for patients with clinical stage I/II
Hodgkin lymphoma (HL). We hypothesized that an early positron emission tomography (…
Hodgkin lymphoma (HL). We hypothesized that an early positron emission tomography (…
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma
…, A Berriolo-Riedinger, S Bardet… - Blood, The Journal …, 2011 - ashpublications.org
… For each patient, the data and images of the PET0, PET2, and PET4 were sent within 24
hours of the examination to ≥ 2 of 3 PET experts (MM, AB-R., or S. Bardet) composing the …
hours of the examination to ≥ 2 of 3 PET experts (MM, AB-R., or S. Bardet) composing the …
Comparison of seven serum thyroglobulin assays in the follow-up of papillary and follicular thyroid cancer patients
…, M Torlontano, F Tenenbaum, S Bardet… - The Journal of …, 2007 - academic.oup.com
Background: Serum thyroglobulin (Tg) is the marker of differentiated thyroid cancer after
initial treatment and TSH stimulation increases its sensitivity for the diagnosis of recurrent …
initial treatment and TSH stimulation increases its sensitivity for the diagnosis of recurrent …
Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma
S Bardet, E Malville, JP Rame, E Babin… - European journal of …, 2008 - academic.oup.com
… In the 24 Group 3 patients, LNR was located in the compartment(s) initially dissected in 8,
in compartment(s) initially dissected and not dissected in 10 and in other compartments than …
in compartment(s) initially dissected and not dissected in 10 and in other compartments than …